$16,000,000
$14,000,000
$12,000,000
$10,000,000
$8,000,000
$6,000,000
$4,000,000
$2,000,000
$0
Net Sales 2006 - 2010
Net Income (Loss) 2006 - 2010
$1,200,000
$1,000,000
$800,000
$600,000
$400,000
$200,000
$0
- $200,000
- $400,000
2006
2007
2008
2009
2010
2006
2007
2008
2009
2010
IKONICS Five-Year History
Net Sales
Pretax Income (Loss)
Net Income (Loss)
2006
2007
2008
2009
2010
$14,888,912
$15,824,725
$15,854,484
$15,121,617
$16,517,338
$1,589,765
$1,635,775
$1,085,134
$(11,360)
$1,553,920
$1,123,765
$1,169,775
$814,134
$(307,360)
$1,113,920
Net Cash Provided by Operations
$1,075,722
$1,697,695
$1,125,668
$1,374,114
$1,601,369
Return on Sales
Return on Assets
Return on Avg. Stockholders' Equity
Debt to Equity
Diluted EPS
Stock price: High
Low
Close
7.5%
10.5%
12.3%
8.9%
$0.55
7.4%
9.8%
11.2%
8.5%
$0.57
$10.47
$10.45
$6.26
$7.53
$7.22
$9.28
5.1%
6.5%
7.2%
9.2%
$0.40
$10.50
$5.25
$5.74
(2.0%)
(2.6%)
(2.7%)
8.8%
$(0.16)
$8.29
$4.00
$6.30
6.7%
8.5%
9.6%
7.8%
$0.56
$8.00
$6.30
$7.25
Weighted Average Common Shares Outstanding - Diluted
2,027,916
2,063,380
2,053,733
1,973,739
1,973,447
Total Assets
Total Liabilities
Total Stockholders' Equity
Capital Spending
$10,743,461
$11,982,417
$12,486,429
$11,997,272
$13,141,931
$879,362
$936,703
$1,052,789
$971,186
$948,984
$9,864,099
$11,045,714
$11,433,640
$11,026,086
$12,192,947
$273,548
$609,772
$4,472,681
$90,313
$189,150
20
1 0
AnnuAl RepoRt
ChRomAline
miCRo-mAChining SolutionS
ikoniCS imAging
induStRiAl inkjet SolutionS
inteRnAtionAl
4832 Grand Avenue Duluth, MN 55807 ph: (218) 628-2217 toll-free: (800) 328-4261 e: info@ikonics.com web: www.ikonics.com
nASdAq liSted: iknx
www.ikonics.com
cover_folder 2010 final.indd 1
4/1/2011 8:38:40 AM
ContentS
letter to Shareholders ............................................................................1
management’s discussion and Analysis of
Financial Condition and Results of operations ..........................................2
Critical Accounting estimates ..................................................................2
Results of operations .............................................................................3
market for Common equity,
Related Stockholder matters and
issuer purchases of equity Securities .......................................................5
management’s Report ............................................................................5
management’s Annual Report on
internal Control over Financial Reporting .................................................5
Report of independent
Registered public Accounting Firm ..........................................................6
Balance Sheets ......................................................................................7
WilliAm C. ullAnd
Chairman, president & Ceo
CompAnY oVeRVieW
ChRomAline SCReen pRint pRoduCtS
globally respected brand, world-wide distribution and technical excellence through-
out the product portfolio, Chromaline continues to serve a critical, strategic role in
the stability and growth of ikoniCS.
Statements of operations .......................................................................8
ikoniCS imAging
Statements of Stockholders’ equity and Comprehensive income ................8
Statements of Cash Flows.......................................................................9
Serving the global awards and recognition market, ikoniCS imaging supplies a
consistent source of revenue and has proven a launch pad for many of ikoniCS’
newer ventures.
notes to Financial Statements .................................................................10
ikoniCS induStRiAl inkjet SolutionS
Board of directors/Corporate officers ......................................................16
ikoniCS Five-Year history .......................................................................Back Cover
Representing one of ikoniCS’ more recent enterprises, digital texturing is poised to
transform the way industrial textures are produced on a wide variety of consumer
and industrial products.
Recent progress on the development of a “direct to metal” application is promising
and represents a potentially critical competitive advantage.
CoRpoRAte pRoFile
ikoniCS miCRo-mAChining
2010 net Sales ................................................................................$16,517,338
earnings per common share (diluted) ............................................................ $0.56
Company founded ....................................................................................... 1952
employees ...................................................................................................... 72
nASdAq Symbol ......................................................................................... iknX
A broad-ranging line of products and services, micro-machining is an excellent
example of leveraging ikoniCS core technological and production competencies
to new markets, such as aerospace, advanced material machining and custom
coating solutions.
ikoniCS inteRnAtionAl
in 2010, ikoniCS recorded sales in 94 countries, representing virtually every offer-
ing within the ikoniCS product roster.
cover_folder 2010 final.indd 2
4/1/2011 8:38:41 AM
Letter to Shareholders
I am pleased to report a year of record sales and robust earnings. Sales were $16,517,000, representing a 9% increase over 2009 with earnings of $1,114,000 or
$0.56 per share compared to a loss of $0.16 per share in 2009. The 2009 loss was caused by the write-off of an investment in imagining Technologies international
in the third quarter of 2009.
A number of our new initiatives achieved commercial success in 2010. During the fourth quarter we sold a Digital Texturing (DTX) V-Jet printer. We were also
granted a European patent on the DTX process in 2010, and applications have been made for similar patents in the US and Japan. Dr. Karl Shaw, a technical and
business leader in the mold texturing industry, has recently joined our DTX team and is assisting in the global introduction of our unique technology.
In 2010, we developed a custom film for the abrasive machining of composite materials used in the aerospace industry, including sound-deadening applications.
This offering has met with growing acceptance from our current customers, and established companies are beginning to convert to our technology. In 2010, we also
developed and applied for a patent on a film designed for the micro-machining of electronic wafers.
As these technologies have graduated from the lab to the market, we have shifted from simply selling products, to providing solutions to industrial consumers, based
on our unique technological strengths. We have modified our organizational structure and our sales model to reflect this new focus. Although we are still developing
technologies that require on-going investment, we are now preparing to benefit from the new technologies we have developed. Our newly named business units:
Micro-Machining Solutions, Industrial Inkjet Solutions and Coating Solutions, along with the appointment of Product Managers for these units, reflect this change of
focus.
Throughout 2010, our traditional businesses continued to be profitable. Export sales grew 17% in 2010 over 2009, due to strong results in both Europe and Latin
America. Chromaline, our domestic screen print stencil business, and PhotoBrasive Systems, our offering to the awards and recognition industry, still suffered from
the effects of the recession and the mature nature of those markets. However, our reorganization also encompasses these businesses, and I am confident that, with
new energy, coupled with aggressive actionable plans, they are positioned for growth.
We ended 2010 in a strong financial position with $3,509,000 in cash and short-term investments, no bank debt, new leadership technologies being introduced to
world markets, and aggressive growth plans for our traditional businesses. I believe 2011 will be a strong year for Ikonics.
William C. Ulland
Chairman, President & CEO
March 22, 2011
The preceding letter contains statements regarding future financial results, new products and other matters that involve risks and uncertainties. The Company’s actual results could differ materially as a result of
domestic and global economic conditions, competitive market conditions, acceptance of new products, as well as the other factors described elsewhere in this Annual Report and in the Company’s most recent
Form 10-K and most recent Form 10-Q on file with the SEC.
1
Management’s Discussion and Analysis of
Financial Condition and Results of Operations
The following management discussion and analysis focuses on those factors that had
a material effect on the Company’s financial results of operations and financial condi-
tion during 2010 and 2009 and should be read in connection with the Company’s
audited financial statements and notes thereto for the years ended December 31,
2010 and 2009, included herein.
Factors that may affect Future Results
Certain statements made in this Annual Report, including those summarized below,
are forward-looking statements within the meaning of the safe harbor provisions of
Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks
and uncertainties, and actual results may differ. Factors that could cause actual
results to differ include those identified below.
The belief that the Company’s current financial resources, cash generated from
operations and the Company’s capacity for debt and/or equity financing will be suf-
ficient to fund current and anticipated business operations and capital expenditures.
The belief that the Company’s low debt levels and available line of credit make it
unlikely that a decrease in product demand would impair the Company’s ability to
fund operations – Changes in anticipated operating results, credit availability, equity
market conditions or the Company’s debt levels may further enhance or inhibit the
Company’s ability to maintain or raise appropriate levels of cash.
The Company’s expectations as to the level and use of planned capital expenditures
and that capital expenditures will be funded with cash generated from operating ac-
tivities – This expectation may be affected by changes in the Company’s anticipated
capital expenditure requirements resulting from unforeseen required maintenance,
repairs or capital asset additions. The funding of planned or unforeseen expenditures
may also be affected by changes in anticipated operating results resulting from de-
creased sales, lack of acceptance of new products or increased operating expenses
or by other unexpected events affecting the Company’s financial position.
The Company’s belief that its vulnerability to foreign currency fluctuations and gen-
eral economic conditions in foreign countries is not significant – This belief may be
impacted by economic, political and social conditions in foreign markets, changes in
regulatory and competitive conditions, a change in the amount or geographic focus of
the Company’s international sales, or changes in purchase or sales terms.
The Company’s plans to continue to invest in research and development efforts, ex-
pedite internal product development and invest in technological alliances, as well as
the expected focus and results of such investments – These plans and expectations
may be impacted by general market conditions, unanticipated changes in expenses or
sales, delays in the development of new products, technological advances, the ability
to find suitable and willing technology partners or other changes in competitive or
market conditions.
The Company’s belief that sales growth will occur in China and India due to
increased sales efforts – These efforts may be impacted by economic, political and
social conditions in these foreign markets, regulatory conditions in such markets,
unanticipated changes in expenses or sales, lack of market acceptance of the
Company’s products, changes in competitive conditions or other barriers to entry or
expansion.
The Company’s belief as to future sources of sales growth and profitability, includ-
ing from photo resist film, export markets and other products the Company sells
– The sources of future increases to the Company’s sales and profitability, and the
Company’s ability to increase sales or profitability at all, may be impacted by lack
of market acceptance for the Company’s products, adverse changes to the global
economy and consumer confidence, the adequacy of the Company’s intellectual prop-
erty protections, the Company’s ability to customize its products for new markets, the
Company’s ability to maintain the quality of its receivables while adding customers in
new markets and the Company’s ability to maintain its reputation for quality products.
Critical Accounting Estimates
The Company prepares its financial statements in conformity with accounting prin-
ciples generally accepted in the United States of America. Therefore, the Company
is required to make certain estimates, judgments and assumptions that the Company
believes are reasonable based upon the information available. These estimates and
assumptions affect the reported amounts of assets and liabilities at the date of the
financial statements and the reported amounts of revenues and expenses during
the periods presented. The accounting estimates which IKONICS believes are the
most critical to aid in fully understanding and evaluating its reported financial results
include the following:
accounts Receivable – The Company performs ongoing credit evaluations of its
customers and adjusts credit limits based upon payment history and the customer’s
current credit worthiness, as determined by review of the current credit information.
The Company continuously monitors collections and payments from its customers and
maintains a provision for estimated credit losses based upon historical experience
and any specific customer collection issues that have been identified. While such
credit losses have historically been within expectations and the provisions established,
the Company cannot guarantee that it will continue to experience the same collection
history that has occurred in the past. The general payment terms are net 30-45
days for domestic customers and net 30-90 days for foreign customers. A small
percentage of the accounts receivable balance are denominated in a foreign currency
with no concentration in any given country. At the end of each reporting period, the
Company analyzes the receivable balance for customers paying in a foreign currency.
These balances are adjusted to each quarter or year spot rate in accordance with
FASB ASC 830, Foreign Currency Matters.
inventory – Inventories are valued at the lower of cost or market value using the last
in, first out (LIFO) method. The Company monitors its inventory for obsolescence and
records reductions from cost when required.
income Taxes – At December 31, 2010, the Company had net current deferred tax
assets of $157,000 and net noncurrent deferred tax liabilities of $171,000. The de-
ferred tax assets and liabilities result primarily from temporary differences in property
and equipment, accrued expenses, and inventory reserves. In connection with the
recording of an impairment charge during 2009 as described below, the Company
has recorded a deferred tax asset and corresponding full valuation allowance in the
amount of $323,000 as it is more likely that this asset will not be realized. The fully
reserved $323,000 deferred tax asset related to the capital loss can be carried back
two years and carried forward four years and must be offset by a capital gain. The
Company has determined that is more likely than not that the remaining deferred tax
assets will be realized and that an additional valuation allowance for such assets in
not currently required. The Company accounts for its uncertain tax positions under
the provision of FASB ASC 740, Income Taxes. At December 31, 2009 the Company
had recorded a liability of $27,000 related to an uncertain tax position which was
eliminated during 2010 and had no reserves for uncertain tax positions at December
31, 2010.
investments in non-marketable Equity Securities – The carrying value of finan-
cial instruments, such as cash, short-term investments, accounts receivable, accounts
payable and accrued liabilities approximate their fair value because of their short
term nature. The Company does not hold or issue financial instruments for trading
purposes. The Company’s investment in non-marketable securities was comprised of
shares in iTi and previously carried at cost. In 2009, the Company recorded an im-
pairment charge of $918,951, reducing the investment in iTi to $0, because iTi was
unable to fund operations, acquire financing or negotiate the sale of the Company.
iTi has since ceased operations and has been liquidated.
Revenue Recognition – The Company recognizes revenue on sales of products
when title passes which can occur at the time of shipment or when the goods ar-
rive at the customer location depending on the agreement with the customer. The
Company sells its products to both distributors and end-users. Sales to distributors
and end-users are recorded based upon the criteria governed by the sales, delivery,
and payment terms stated on the invoices from the Company to the purchaser. In
addition to transfer of title / risk of loss, all revenue is recorded in accordance with
2
iKOniCS Corporation 2010 Annual Report
the criteria outlined within SAB 104 and FASB ASC 605 Revenue Recognition:
a.) persuasive evidence of an arrangement (principally in the form of customer
sales orders and the Company’s sales invoices)
b.) delivery and performance (evidenced by proof of delivery, e.g. the shipment
of film and substrates with bill of lading used for proof of delivery for FOB
shipping point terms, and the carrier booking confirmation report used for
FOB destination terms). Once the finished product is shipped and physically
delivered under the terms of the invoice and sales order, the Company has no
additional performance or service obligations to complete
c.) a fixed and determinable sales price (the Company’s pricing is established
and is not based on variable terms, as evidenced in either the Company’s
invoices or the limited number of distribution agreements; the Company rarely
grants extended payment terms and has no history of concessions)
d.) a reasonable likelihood of payment (the Company’s terms are standard, and
the Company does not have a substantial history of customer defaults or
non-payment)
Sales are reported on a net basis by deducting credits, estimated normal returns and
discounts. The Company’s return policy does not vary by geography. The customer
has no rotation or price protection rights and the Company is not under a warranty
obligation except for a minimal obligation related to six months of service on the DTX
printer sold in 2010. Freight billed to customers is included in sales. Shipping costs
are included in cost of goods sold.
Results of Operations
YEaR EndEd dECEmbER 31, 2010 COmpaREd TO YEaR EndEd dECEmbER 31, 2009
Sales – The Company’s net sales increased 9.2% in 2010 to a record $16.5 million
compared to net sales of $15.1 million in 2009. Strong sales in Europe and Latin
America drove a 17.1% Export sales increase for 2010 compared to 2009. IKONICS
Imaging also realized a 19.9% sales increase over 2009. Over one-half of the IKON-
ICS Imaging sales increase was related to the Company’s new business initiatives.
Sales to the awards and trophy market also grew in 2010. Partially offsetting these
sales increases, Domestic sales decreased 2.0% in 2010 due to lower private label
film shipments.
Gross profit – Gross profit was $6.8 million, or 41.1% of sales, in 2010 and $6.1
million, or 40.1% of sales, in 2009. Export gross profit percentage increased to
30.0% in 2010 compared to 26.5% in 2009 due to higher volumes and an improved
sales mix. Improved volumes and sales mix also accounted for IKONICS Imaging’s
gross profit percentage increase from 44.3% in 2009 to 45.5% in 2010. Domestic
gross profit percentage improved slightly from 47.1% in 2009 to 47.4% in 2010.
Selling, General and administrative Expenses – Selling, general and administra-
tive expenses of $4.6 million, or 27.7% of sales, in 2010 were comparable to selling
general and administrative expenses in 2009 of $4.5 million, or 30.0% of sales.
Research and development Expenses – Research and development expenses
in 2010 were $696,000, or 4.2% of sales, versus $654,000, or 4.3% of sales, in
2009. The 2010 increase is related primarily to the $31,000 abandonment of patent
applications. The Company records patent application costs as an asset and amor-
tizes those costs upon successful completion of the application process or expenses
those costs when an application is abandoned.
Gain on Sale of non-marketable Equity Securities – The Company realized a
gain of $29,800 in 2009 on the sale of its investment in the common and preferred
stock of Apprise Technologies, Inc. The original sale took place during 2007. The fi-
nal $29,800 received in 2009 was related to a portion of the original sales price that
was placed in escrow at the time of the sale for indemnification obligations as part of
the agreement between Apprise and its purchaser. The Company did not have any
non-marketable equity securities as of December 31, 2010 and accordingly did not
have any gain on any such securities during 2010.
loss on investment in non-marketable Equity Securities – The Company’s 2009
investment in non-marketable securities was comprised of shares in iTi and was
previously carried at cost. Non-marketable securities are not adjusted to fair value
on a recurring basis; however, they are assessed for an other than temporary decline
in fair value. A decline in the market value for these securities that is determined to
be other than temporary results in a revaluation of its carrying amount to fair value.
An impairment analysis was conducted in accordance with applicable accounting
standards in 2009, and the Company recorded an impairment charge of $919,000,
which represents a full write-off of the Company’s investment in iTi to $0. The
Company did not have any loss on investments in non-marketable equity securities in
2010.
interest income – The Company earned $19,700 of interest income in 2010
compared to $8,000 in 2009. The interest earned in 2010 and 2009 is related to
interest received from the Company’s short-term investments, which consist of fully
insured certificates of deposit with remaining maturities ranging from 2 to 12 months.
income Taxes – During 2010, the Company realized income tax expense of
$440,000, or an effective rate of 28.3%, compared to income tax expense of
$296,000 in 2009. Income tax expense in 2010 and 2009 was impacted by
derecognizing a liability for unrecognized tax benefits relating to a tax year where the
statute of limitations expired during the year. A $27,000 liability was derecognized
in 2010 while a $21,000 liability was derecognized in 2009. During 2010, the
Company also recorded an out-of-period tax benefit adjustment of $15,000 relating
to December 31, 2009 estimates for tax credits as well as the receipt of interest of
approximately $13,000 related to Minnesota state income tax returns. Income tax
expense in 2010 and 2009 also benefitted from the domestic manufacturing deduc-
tion, and research and development credits. In 2009 the Company did not receive a
tax benefit from the $919,000 loss on investment in non-marketable equity securities
since the Company recorded a full valuation allowance against the deferred tax asset
resulting from the loss on the capital asset impairment charge, as it is currently more
likely that the deferred tax asset will not be realized.
Liquidity and Capital Resources
The Company has financed its operations principally with funds generated from op-
erations. These funds have been sufficient to cover the Company’s normal operating
expenditures, annual capital requirements, and research and development expendi-
tures.
Cash was $1,291,000 and $1,305,000 at December 31, 2010 and 2009, respec-
tively. In addition to its cash, the Company also held $2,218,000 of short term
investments as of December 31, 2010 and $802,000 of short term investments as
of December 31, 2009. The Company generated $1,601,000 in cash from operating
activities during 2010, compared to generating $1,374,000 of cash from operating
activities in 2009. Cash provided by operating activities is primarily the result of
the net income (loss) adjusted for non-cash loss and gain on investments, non-cash
depreciation and amortization, loss on intangible asset abandonment, deferred
taxes, and certain changes in working capital components discussed in the following
paragraph.
During 2010, trade receivables decreased by $132,000. The decrease in receiv-
ables was driven by improved collection related to an improved economy. Inventory
levels increased $127,000 due to higher levels of raw material and finished goods to
support the increase in sales volumes. Prepaid expenses and other assets increased
$3,000. Accounts payable increased $155,000 due to of the timing of payments to
and purchases from vendors. Accrued liabilities decreased $114,000 due to the tim-
ing of payroll and the derecognizing of a liability for unrecognized tax benefits relating
to a tax year where the statute of limitations expired during the year. Income taxes
payable decreased $73,000 reflecting 2010 estimated tax payments.
During 2010, investing activities used $1,637,000. The Company invested
$2,621,000 in fully insured certificates of deposits with six $200,000 certificates
of deposit maturing during 2010. Purchases of property and equipment totaled
$189,000. These capital expenditures were mainly for production equipment and
three vehicles for sales persons. The Company received $22,000 from vehicle and
3
equipment sales during 2010. Also during 2010, the Company incurred $54,000 in
patent application costs that the Company records as an asset and amortizes upon
successful completion of the application process.
During 2009, investing activities used $847,000. The Company invested $1,002,000
in fully insured certificates on deposits with one $200,000 certificate of deposit
maturing during 2009. Purchases of property and equipment were $90,000, mainly
for new equipment to support the Company’s new business initiatives and research
activities. Also during 2009, the Company incurred $10,000 in patent application
costs that the Company records as an asset and amortizes upon successful comple-
tion of the application process or expenses if the application is abandoned. The
Company received proceeds of approximately $30,000 in 2009 on the 2007 sale of
its investment in the common and preferred stock of Apprise Technologies, Inc. and
$26,000 for the sale of equipment and vehicles.
During 2010 the Company received $23,000 from financing activities. The Company
received $37,000 from the issuance of 8,500 shares of common stock from the
exercise of stock options and the Company repurchased 2,200 shares of it own stock
for $15,000. The Company used $124,000 in financing activities during 2009 to
repurchase 26,926 shares of its own stock
A bank line of credit exists providing for borrowings of up to $1,250,000. The line
of credit is collateralized by trade receivables and inventory and bears interest at 2.5
percentage points over the 30-day LIBOR rate. The Company did not utilize this line
of credit during 2010 and 2009 and there were no borrowings outstanding as of
December 31, 2010 and 2009. There are no financial covenants related to the line
of credit.
The Company believes that current financial resources, its line of credit, cash gener-
ated from operations and the Company’s capacity for debt and/or equity financing will
be sufficient to fund current and anticipated business operations. The Company also
believes that its low debt levels and available line of credit make it unlikely that a
decrease in demand for the Company’s products would impair the Company’s ability
to fund operations.
Capital Expenditures
In 2010, the Company had $189,000 in capital expenditures. These capital expendi-
tures were mainly for production equipment and three vehicles for sales persons.
In 2009, the Company made $90,000 in capital expenditures, mainly for equipment
to support the Company’s new business initiatives and research activities.
The Company expects capital expenditures in 2011 of approximately $600,000.
Plans for capital expenditures include two mandatory elevator and manufacturing
equipment upgrades, development equipment to modernize the capabilities and pro-
cesses of IKONICS’ laboratory, research and development to improve measurement
and quality control processes and a vehicle. These commitments are expected to be
funded with cash generated from operating activities.
economic hedging strategy to reduce the risk of foreign currency translation expo-
sures, which management does not believe to be significant based on the scope and
geographic diversity of the Company’s foreign operations as of December 31, 2010.
Furthermore, the impact of foreign exchange on the Company’s balance sheet and
operating results was not material in either 2010 or 2009.
Future Outlook
IKONICS has spent on average over 4% of its sales dollars for the past few years in
research and development and has made capital expenditures related to its digital
technology program. The Company plans to maintain its efforts in this area and
expedite internal product development as well as form technological alliances with
outside experts to commercialize new product opportunities.
In 2010, the Company made substantial progress on its new business initiatives.
Photomachining and sound deadening were in commercial operation supplying prod-
uct to major electronics, defense and aerospace customers. A DTX printer was sold
in the fourth quarter of 2010; it is performing to expectations and generating sales
of related consumables. In 2010, the Company entered into a strategic alliance with
Colour Scanner Technology GMBH for the supply and marketing of DTX printers. The
Company was also awarded a European patent on its DTX technology in 2010.
In 2010, the Company developed and applied for a patent on its I-HE photo resist
film for the etching of electronic wafers and developed I-XE low silicone photo resist
film for the aerospace industry. The Company believes both films have been well
received and have begun to generate profitable sales which the Company believes
will continue in 2011.
Export sales grew by 17% in 2010 and the Company expects continued growth in
2011 as the Company will continue efforts to grow its business internationally by
attempting to develop new markets and expanding market share where it has already
established a presence.
In 2010, the Company’s traditional domestic screen print stencil business was flat.
The Company anticipates growth in this area in 2011 with an improving economy
and new sales efforts. Sales to the awards and recognition market of the Company’s
sandblast resist films rebounded in 2010 with the improving economy, and the Com-
pany expects that trend to continue in 2011.
Other future activities undertaken to expand the Company’s business may include
acquisitions, building improvements, equipment additions, new product development
and marketing opportunities.
Off-Balance Sheet Arrangements
The Company has no off-balance sheet arrangements.
Recent Accounting Pronouncements
International Activity
None
The Company markets its products in numerous countries in all regions of the world,
including North America, Europe, Latin America, and Asia. The Company’s 2010 for-
eign sales of $5,421,000 were approximately 32.8% of total sales, compared to the
2009 foreign sales of $4,629,000, which were 30.6% of total sales. The increase in
foreign sales in 2010 was primarily due to growth in both Europe and Latin America.
The Company anticipates sales growth in India and China due to increased sales
efforts. Fluctuations in certain foreign currencies have not significantly impacted the
Company’s operations because the Company’s foreign sales are not concentrated
in any one region of the world. The Company believes its vulnerability to uncertain-
ties due to foreign currency fluctuations and general economic conditions in foreign
countries is not significant.
The Company’s foreign transactions are primarily negotiated, invoiced and paid in
U.S. dollars, while a portion is transacted in Euros. IKONICS has not implemented an
4
iKOniCS Corporation 2010 Annual Report
Market for Common Equity, Related Stockholder
Matters and Issuer Purchases of Equity Securities
Management’s Annual Report on Internal Control Over
Financial Reporting
The Company’s Common Stock is traded on the Nasdaq Capital Market under the
symbol IKNX. The following table sets forth, for the fiscal quarters indicated, the high
and low sales prices for the Company’s Common Stock as reported on the Nasdaq
Capital Market for the periods indicated.
Fiscal Year Ended december 31, 2010:
First Quarter
Second Quarter
Third Quarter
Fourth Quarter
Fiscal Year Ended december 31, 2009:
First Quarter
Second Quarter
Third Quarter
Fourth Quarter
$
$
$
$
High
7.16
7.50
7.32
8.00
5.80
6.87
7.98
8.29
low
6.30
6.52
6.40
6.91
4.00
4.35
5.50
6.30
As of February 23, 2011, the Company had approximately 596 shareholders. The
Company has never declared or paid any dividends on its Common Stock.
In prior years, the Company’s board of directors had authorized the repurchase of
250,000 shares of common stock. A total of 216,969 shares have been repur-
chased under this program including 2,200 shares repurchased during 2010. The
plan allows for an additional 33,031 shares to be repurchased.
For Year Ended dec.
31, 2010
Total number of
Shares purchased
average price paid
per Share
Total number of
Shares purchased
as part of publicly
announced plans or
programs
maximum number
of Shares that may
Yet be purchased
Under The plans or
programs
Jan. 1 – Jul. 31
Aug. 1 – Aug. 31
Sep. 1 – Dec. 31
-
2,200
-
2,200
-
$6.88
-
$6.88
-
2,200
-
2,200
35,231
33,031
33,031
33,031
Management’s Report
The financial statements of IKONICS Corporation have been prepared by Company
management who are responsible for their content. These statements have been
prepared in accordance with accounting principles generally accepted in the United
States of America and, where appropriate, reflect estimates based on judgements of
management.
The financial statements have been audited by McGladrey & Pullen LLP, an indepen-
dent registered public accounting firm.
The Audit Committee of the Board of Directors, comprised of outside directors, meets
periodically with the independent auditors and management to discuss the company’s
internal accounting controls and financial reporting matters. Our independent regis-
tered public accounting firm has unrestricted access to the Audit Committee, without
management present, to discuss the results of their audit, the adequacy of internal
accounting controls, and the quality of financial reports.
William C. Ulland
Chairman, President & CEO
JOn GERlaCH
Chief Financial Officer & V.P. Finance
Our management is responsible for establishing and maintaining adequate internal
control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f)under
the Exchange Act. Our internal control system is designed to provide reasonable
assurance to our management and board of directors regarding the reliability of
financial reporting and the preparation of financial statements for external purposes
in accordance with generally accepted accounting principles. Our internal control over
financial reporting includes those policies and procedures that:
Pertain to the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the Company;
Provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the Company are being made only in
accordance with authorizations of management and directors of the Company; and
Provide reasonable assurance regarding prevention or timely detection of unauthor-
ized acquisition, use or disposition of the Company’s assets that could have a mate-
rial effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not
prevent or detect misstatements. Also, projections of any evaluation of effective-
ness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies
or procedures may deteriorate.
Management assessed the effectiveness of our internal control over financial report-
ing as of December 31, 2010. In making this assessment, management used the
criteria set forth by the Committee of Sponsoring Organizations of the Treadway Com-
mission (COSO) in Internal Control – Integrated Framework. Based on management’s
assessment and those criteria, management believes that, as of December 31, 2010,
the Company maintained effective internal control over financial reporting.
This annual report does not include an attestation report of the Company’s inde-
pendent registered public accounting firm regarding internal control over financial
reporting. Our management’s report of the effectiveness on the design and operation
of our internal control over financial reporting was not subject to attestation by the
Company’s independent registered public accounting firm pursuant to temporary rules
of the Securities and Exchange Commission that permit the Company to provide only
management’s report in this annual report.
William C. Ulland
Chairman, President & CEO
JOn GERlaCH
Chief Financial Officer & V.P. Finance
5
Report of Independent Registered Public Accounting Firm
To the board of directors and Stockholders
iKOniCS Corporation
We have audited the accompanying balance sheets of IKONICS Corporation as of December 31, 2010 and 2009, and the related statements of operations, stockholders’ equity,
and cash flows for the years then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these
financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we
engaged to perform an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing
audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial
reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial state-
ments, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe
that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of IKONICS Corporation as of December 31, 2010 and
2009, and the results of its operations and its cash flows for the years then ended in conformity with U.S. generally accepted accounting principles.
/s/ McGladrey & Pullen, LLP
Duluth, Minnesota
March 3, 2011
6
iKOniCS Corporation 2010 Annual Report
BALANCE SHEETS
dECEmbER 31, 2010 and 2009
Assets
Current assets:
2010
2009
Cash (Note 7) ........................................................................................................................................................................
$
1,291,383
$
1,304,586
Short-term investments .........................................................................................................................................................
Trade receivables, less allowance of $60,000 in 2010 and $78,000 in 2009 (Notes 5, 7, and 8) ............................................
Inventories (Notes 1 and 8) ....................................................................................................................................................
Prepaid expenses and other assets ........................................................................................................................................
Deferred income taxes (Note 2) ..............................................................................................................................................
2,217,990
1,883,428
2,198,064
63,965
157,000
Total current assets ...............................................................................................................................................................
7,811,830
property, plant, and Equipment, at Cost:
Land and building ..................................................................................................................................................................
Machinery and equipment .....................................................................................................................................................
Office equipment ...................................................................................................................................................................
Vehicles ................................................................................................................................................................................
Less accumulated depreciation ..............................................................................................................................................
5,888,445
2,455,238
642,100
234,650
9,220,433
4,207,500
5,012,933
802,165
2,015,798
2,070,602
61,337
163,000
6,417,488
5,883,794
2,456,218
741,895
241,006
9,322,913
4,088,669
5,234,244
intangible assets, less accumulated amortization of $376,983 in 2010 and $325,576 in 2009 (Note 3) ...............................
317,168
345,540
Liabilities And Stockholders’ Equity
Current liabilities:
$
13,141,931
$
11,997,272
2010
2009
Accounts Payable ..................................................................................................................................................................
$
Accrued compensation ..........................................................................................................................................................
Other accrued liabilities (Note 2) ............................................................................................................................................
Income taxes payable ............................................................................................................................................................
Total current liabilities ............................................................................................................................................................
deferred income Taxes (Note 2) ..........................................................................................................................................
Total liabilities ........................................................................................................................................................................
Stockholders’ Equity:
Preferred stock, par value $.10 per share; authorized 250,000 shares: issued none
Common stock, par value $.10 per share; authorized 4,750,000 shares: issued and outstanding 1,973,357 shares in 2010
and 1,967,057 shares in 2009 (Note 6) ................................................................................................................................
Additional paid-in capital........................................................................................................................................................
Retained earnings ..................................................................................................................................................................
$
441,830
282,196
45,868
8,090
777,984
171,000
948,984
286,610
337,365
104,408
80,803
809,186
162,000
971,186
-
-
197,336
2,263,176
9,732,435
196,706
2,198,289
8,631,091
Total stockholders’ equity .......................................................................................................................................................
12,192,947
11,026,086
$
13,141,931
$
11,997,272
See notes to financial statements.
7
Statements Of Operations
YEARS ENDED DECEMBER 31, 2010 AND 2009
NET SALES ...........................................................................................................................................................................
$
16,517,338
$
15,121,617
2010
2009
COST OF GOODS SOLD ........................................................................................................................................................
GROSS PROFIT .....................................................................................................................................................................
SELLING, GENERAL AND ADMINSTRATIVE EXPENSES .............................................................................................................
RESEARCH AND DEVELOPMENT EXPENSES ...........................................................................................................................
INCOME FROM OPERATIONS.................................................................................................................................................
GAIN ON SALE OF NON-MARKETABLE EQUITY SECURITIES ....................................................................................................
LOSS ON INVESTMENT IN NON-MARKETABLE EQUITY SECURITIES ........................................................................................
INTEREST INCOME ................................................................................................................................................................
INCOME (LOSS) BEFORE INCOME TAXES ...............................................................................................................................
FEDERAL AND STATE INCOME TAXES (NOTE 2) .....................................................................................................................
9,713,054
6,804,284
4,574,452
695,593
5,270,045
1,534,239
-
-
19,681
1,553,920
440,000
NET INCOME (LOSS) .............................................................................................................................................................
$
1,113,920
EARNINGS (LOSS) PER COMMON SHARE: .............................................................................................................................
Basic ...............................................................................................................................................................................
Diluted .............................................................................................................................................................................
WEIGHTED AVERAGE COMMON SHARES: ..............................................................................................................................
Basic ...............................................................................................................................................................................
Diluted .............................................................................................................................................................................
$
$
0.56
0.56
1,971,717
1,973,447
$
$
$
9,054,771
6,066,846
4,543,448
653,747
5,197,195
869,651
29,762
(918,951)
8,178
(11,360)
296,000
(307,360)
(0.16)
(0.16)
1,973,739
1,973,739
See notes to financial statements.
Statements Of Stockholders’ Equity
YEaRS EndEd dECEmbER 31, 2010 and 2009
balance at december 31, 2008
Net loss
Common Stock Repurchased
Stock based compensation and related tax benefit
Common Shares
Stock amount
additional paid-in
Capital
Retained Earnings
Total Stockholders’
Equity
1,993,983
$
199,398
$
2,202,888
$
9,031,354
$
11,433,640
-
(26,926)
-
-
(2,692)
-
-
(28,249)
23,650
(307,360)
(92,903)
-
8,631,091
1,113,920
-
(12,576)
-
(307,360)
(123,844)
23,650
11,026,086
1,113,920
37,740
(15,130)
914
29,417
balance at december 31, 2009
1,967,057
196,706
2,198,289
Net income
Exercise of stock options
Common stock repurchased
Tax benefit resulting from stock option exercises
Stock based compensation and related tax benefit
-
8,500
(2,200)
-
-
850
(220)
-
-
36,890
(2,334)
914
29,417
balance at december 31, 2010
See notes to financial statements.
1,973,357
$
197,336
$
2,263,176
$
9,732,435
$
12,192,947
8
iKOniCS Corporation 2010 Annual Report
Statements Of Cash Flows
YEaRS EndEd dECEmbER 31, 2010 and 2009
CASH FLOWS FROM OPERATING ACTIVITIES:
2010
2009
Net income (loss)..................................................................................................................................................................
$
1,113,920
$
(307,360)
ADJUSTMENTS TO RECONCILE NET INCOME (LOSS) TO NET CASH PROVIDED BY OPERATING ACTIVITIES:
Depreciation .........................................................................................................................................................................
Amortization .........................................................................................................................................................................
Stock based compensation ...................................................................................................................................................
(Gain) loss on sale of equipment and vehicles .......................................................................................................................
Loss on intangible asset abandonment ..................................................................................................................................
Gain on sale of non-marketable equity securities ...................................................................................................................
Loss on investment in non-marketable equity securities .........................................................................................................
402,027
51,407
29,417
(13,766)
31,372
-
-
Deferred income taxes ..........................................................................................................................................................
15,000
CHANGES IN WORKING CAPITAL COMPONENTS:
Trade receivables..................................................................................................................................................................
Inventories ...........................................................................................................................................................................
Prepaid expenses and other assets .......................................................................................................................................
Income tax refund receivable ................................................................................................................................................
Accounts payable .................................................................................................................................................................
Accrued liabilities .................................................................................................................................................................
Income taxes payable ..........................................................................................................................................................
132,370
(127,462)
(2,628)
-
155,220
(113,709)
(71,799)
Net cash provided by operating activities...........................................................................................................................
1,601,369
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment ...................................................................................................................................
Proceeds from sale of equipment and vehicles ......................................................................................................................
Purchases of intangibles .......................................................................................................................................................
Purchases of short-term investments ....................................................................................................................................
Proceeds from sale of short-term investments .......................................................................................................................
Proceeds from sale of non-marketable equity securities .........................................................................................................
(189,150)
22,200
(54,407)
(2,621,393)
1,205,568
-
Net cash used in investing activities ..................................................................................................................................
(1,637,182)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repurchase of common stock ..............................................................................................................................................
Proceeds from exercise of stock options ...............................................................................................................................
Net cash provided by (used in) financing activities ............................................................................................................
(15,130)
37,740
22,610
424,573
55,251
23,650
8,059
12,700
(29,762)
918,951
(48,000)
61,360
38,562
130,864
185,869
(178,173)
(3,233)
80,803
1,374,114
(90,313)
25,500
(10,206)
(1,002,165)
200,000
29,762
(847,422)
(123,844)
-
(123,844)
NET INCREASE (DECREASE) IN CASH .......................................................................................................................................
(13,203)
402,848
CASH AT BEGINNING OF YEAR ..................................................................................................................................................
1,304,586
901,738
CASH AT END OF YEAR ............................................................................................................................................................
$
1,291,383
$
1,304,586
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for income taxes, net of refunds received of $81,422 and $119,423, respectively ...............................................
$
531,799
$
96,380
See notes to financial statements.
9
Notes To Financial Statements
YEaRS EndEd dECEmbER 31, 2010 and 2009
depreciation - Depreciation of property, plant and equipment is computed using the
straight-line method over the following estimated useful lives:
1. Summary Of Significant accounting policies
description of business and Foreign Export Sales - IKONICS Corporation (the
Company) develops and manufactures high-quality photochemical imaging systems
for sale primarily to a wide range of printers and decorators of surfaces. Custom-
ers’ applications are primarily screen printing and abrasive etching. The Company’s
principal markets are throughout the United States. In addition, the Company sells
to Europe, Latin America, Asia, and other parts of the world. The Company extends
credit to its customers, all on an unsecured basis, on terms that it establishes for
individual customers.
Foreign export sales approximated 32.8% of net sales in 2010 and 30.6% of net
sales in 2009. The Company’s accounts receivable at December 31, 2010 and 2009
due from foreign customers were 38.5% and 36.7%, respectively. The foreign export
receivables are composed primarily of open credit arrangements with terms ranging
from 30 to 90 days. No single customer represented greater than 10% of net sales
in 2010 or in 2009.
The Company considers events or transactions that occur after the balance sheet
date but before the financial statements are issued to provide additional evidence
relative to certain estimates or to identify matters that require additional disclosure.
Subsequent events have been evaluated through March 3, 2011, the date the finan-
cial statements were issued.
A summary of the Company’s significant accounting policies follows:
Short-Term investments - Short-term investments consist of $2,217,990 and
$802,165 of fully insured certificates of deposit with maturities ranging from one to
twelve months as of December 31, 2010 and 2009, respectively.
Trade Receivables – Trade receivables are carried at original invoice amount
less an estimate made for doubtful receivables based on a review of all outstanding
amounts on an on-going basis. Management determines the allowance for doubtful
accounts by regularly evaluating individual customer receivables and considering a
customer’s financial condition, credit history, and current economic conditions. Trade
receivables are written off when deemed uncollectible. Recoveries of trade receiv-
ables previously written off are recorded when received. Accounts are considered
past due if payment is not received according to agreed-upon terms.
A small percentage of the accounts receivable balance is denominated in a foreign
currency with no concentration in any given country. At the end of each report-
ing period, the Company analyzes the receivable balance for customers paying in a
foreign currency. These balances are adjusted to each quarter or year spot rate in
accordance with FASB ASC 830, Foreign Currency Matters. Foreign currency trans-
actions and translation adjustments did not have a significant effect on the Balance
Sheet or the Statements of Stockholders’ Equity and Cash Flows for 2010 and 2009.
inventories - Inventories are stated at the lower of cost or market using the last-in,
first-out (LIFO) method. If the first-in, first-out cost method had been used, invento-
ries would have been approximately $993,000 and $893,000 higher than reported
at December 31, 2010 and 2009, respectively. During 2009, certain inventory
quantities were reduced, which resulted in liquidations of LIFO inventory layers. The
liquidations decreased cost of goods sold by approximately $59,000 in 2009. No
layers were liquidated in 2010. The major components of inventories, net of the
allowance for obsolescence, are as follows:
Raw materials
Work-in-progress
Finished goods
Reduction to LIFO cost
Total inventories
10
2010
2009
$
1,403,875
$
1,333,549
294,006
1,493,226
277,876
1,351,736
(993,043)
(892,559)
$
2,198,064
$
2,070,602
Buildings ................................................
Machinery and equipment ......................
Office equipment ....................................
Vehicles .................................................
Years
15-40
5-10
3-10
3
intangible assets – Intangible assets consist primarily of patents, licenses and
covenants not to compete arising from business combinations. Intangible assets
are amortized on a straight-line basis over their estimated useful lives or agreement
terms. Intangible assets with finite lives are assessed for impairment whenever
events or circumstances indicate the carrying value may not be fully recoverable by
comparing the carrying value of the intangibles to their future undiscounted cash
flows. To the extent the undiscounted cash flows are less than the carrying value,
analysis is performed based on several criteria, including, but not limited to, revenue
trends, discounted operating cash flows and other operating factors to determine the
impairment amount.
As of December 31, 2010 the remaining estimated weighted average useful lives of
intangible assets are as follows:
Patents ..................................................
Licenses ................................................
Non-compete agreements.......................
Years
16.5
5.0
3.5
Fair Value of Financial instruments – The carrying amounts of financial instru-
ments, including cash, short-term investments, accounts receivable, accounts pay-
able, and accrued liabilities approximate fair value due to the short maturity of these
instruments.
Revenue Recognition - The Company recognizes revenue on sales of products
when title passes which can occur at the time of shipment or when the goods ar-
rive at the customer location depending on the agreement with the customer. The
Company sells its products to both distributors and end-users. Sales to distributors
and end-users are recorded based upon the criteria governed by the sales, delivery,
and payment terms stated on the invoices from the Company to the purchaser. In
addition to transfer of title / risk of loss, all revenue is recorded in accordance with
the criteria outlined within SAB 104 and FASB ASC 605 Revenue Recognition:
(a) persuasive evidence of an arrangement (principally in the form of customer sales
orders and the Company’s sales invoices, as generally there is no other formal agree-
ment underlying the sale transactions)
(b) delivery and performance (evidenced by proof of delivery, e.g. the shipment of film
and substrates with bill of lading used for proof of delivery for FOB shipping point
terms, and the carrier booking confirmation report used for FOB destination terms).
Once the finished product is shipped and physically delivered under the terms of
the invoice and sales order, the Company has no additional performance or service
obligations to complete
(c) a fixed and determinable sales price (the Company’s pricing is established and is
not based on variable terms, as evidenced in either the Company’s invoices or the
limited number of distribution agreements; the Company rarely grants extended pay-
ment terms and has no history of concessions)
(d) a reasonable likelihood of payment (the Company’s terms are standard, and the
Company does not have a substantial history of customer defaults or non-payment)
Sales are reported on a net basis by deducting credits, estimated normal returns and
discounts. The Company’s return policy does not vary by geography. The customer
has no rotation or price protection rights and the Company is not under a warranty
obligation except for a minimal obligation related to six months of service on the DTX
printer sold in 2010. Freight billed to customers is included in sales. Shipping costs
are included in cost of goods sold.
iKOniCS Corporation 2010 Annual Report
deferred Taxes - Deferred taxes are provided on a liability method whereby deferred
tax assets are recognized for deductible temporary differences and operating loss
and tax credit carryforwards and deferred tax liabilities are recognized for taxable
temporary differences. Temporary differences are the differences between the
reported amounts of assets and liabilities and their tax bases. Deferred tax assets
are reduced by a valuation allowance when, in the opinion of management, it is more
likely than not that some portion or all of the deferred tax assets will not be realized.
Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws
and rates on the date of enactment.
Earnings (loss) per Common Share (EpS) - Basic EPS is calculated using net
income divided by the weighted average of common shares outstanding. Diluted EPS
is similar to Basic EPS except that the weighted average number of common shares
outstanding is increased to include the number of additional common shares, when
dilutive, that would have been outstanding if the potential dilutive common shares,
such as those shares subject to options, had been issued. For the year ended
December 31, 2009, the effect of all stock-based awards were anti-dilutive due to
the net loss incurred and, therefore, they were not included in the computation of per
share amounts.
Shares used in the calculation of diluted EPS are summarized below:
Weighted average common shares
outstanding ...............................................................
1,971,717
1,973,739
2010
2009
The expected provision (benefit) for income taxes, computed by applying the U.S. fed-
eral income tax rate of 35% in 2010 and 2009 to income before taxes, is reconciled
to income tax expense as follows:
Expected provision (benefit) for federal
income taxes ....................................................
State income taxes, net of federal benefit ..........
Reversal of uncertain tax positions ....................
Domestic manufacturers deduction....................
Non-deductible meals, entertainment, and
life insurance ....................................................
Valuation allowance for capital loss on invest-
ment in non-marketable equity securities ..........
Research and development credit......................
Other ...............................................................
2010
2009
$ 544,000
$
(5,000)
(2,100)
(27,000)
(50,100)
15,300
(21,000)
(12,800)
20,400
16,300
-
(16,600)
(28,600)
331,000
(14,800)
(13,000)
$ 440,000
$ 296,000
Net deferred tax assets (liabilities) consist of the following as of December 31, 2010
and 2009:
2010
2009
Dilutive effect of stock options ...................................
1,730
-
Accrued vacation ..............................................
$
21,000
$
23,000
Weighted average common and common equivalent
shares outstanding ....................................................
1,973,447
1,973,739
At December 31, 2010, options to purchase 16,250 shares of common stock with
a weighted average exercise price of $7.89 were outstanding, but were excluded
from the computation of common share equivalents because they were anti-dilutive.
If the Company had been in a net income position in 2009, 28,000 options with a
weighted average exercise price of $4.83 would have been included as part of the
weighted average common as the options would have been dilutive.
Employee Stock plan - The Company accounts for employee stock options under
the provision of ASC 718 Compensation – Stock Compensation.
Use of Estimates - The preparation of the financial statements in conformity with
accounting principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses during
the reporting period. Actual results could differ from those estimates. Significant
estimates include the allowance for doubtful accounts receivable, the reserve for
inventory obsolescence and the valuation allowance for deferred tax assets
2. income Taxes
Income tax expense (benefit) for the years ended December 31, 2010 and 2009
consists of the following:
2010
2009
Current:
Federal ...............................................................
$ 428,000
$ 325,000
State ..................................................................
deferred............................................................
(3,000)
425,000
15,000
19,000
344,000
(48,000)
$ 440,000
$ 296,000
Inventories ........................................................
113,000
Allowance for doubtful accounts ........................
Allowance for sales returns ...............................
Capital loss carryforward ...................................
Less valuation allowance...................................
deferred tax liabilities:
Property and equipment and other assets..........
Intangible assets ...............................................
Prepaid expenses .............................................
12,000
11,000
323,000
(323,000)
157,000
(160,000)
(11,000)
-
114,000
18,000
11,000
331,000
(331,000)
166,000
(160,000)
(3,000)
(2,000)
Net deferred tax assets (liabilities) .....................
$
(14,000)
$
1,000
The deferred tax amounts described above have been included in the accompanying
balance sheet as of December 31, 2010 and 2009 as follows:
Current assets
Noncurrent assets (liabilities)
2010
2009
$ 157,000
$ 163,000
(171,000)
(162,000)
$
(14,000)
$
1,000
At December 31, 2010 and 2009, the Company established a valuation allowance
against its deferred tax asset related to the Company’s $919,000 loss on its invest-
ment in non-marketable equity securities since it is more likely that the deferred
tax asset will not be realized. The deferred tax asset and valuation allowance at
December 31, 2010 and December 31, 2009 was $323,000 and $331,000, respec-
tively. In 2010 the Company was able to offset $8,000 of the deferred tax asset with
the gain realized on its 2007 sale of its investments in Apprise Technologies. As of
December 31, 2010 the remaining deferred tax asset related to the capital loss can
be carried back two years and carried forward four years and must be offset by a
capital gain.
The Company accounts for its uncertain tax positions under the provisions of FASB
ASC 740, Income Taxes. During 2010 and 2009, the statute of limitations for the
relevant taxing authority to examine and challenge the tax position for open years
expired, resulting in decreases in income tax expense of $27,000 in 2010 and
11
$21,000 in 2009. As of December 31, 2010, there was no liability for unrecognized
tax benefits compared to a liability of $27,000 as of December 31, 2009. The li-
ability for unrecognized tax benefits was included in other accrued liabilities.
It has been the Company’s policy to recognize interest and penalties related to un-
certain tax positions in income tax expense. The Company had accrued approximately
$8,000 of interest related to uncertain tax positions at December 31, 2009. The
unrecognized tax benefits at December 31, 2009 relate to taxation of foreign export
sales. At December 31, 2010 there is no accrual for interest related to uncertain tax
positions as there is no liability for unrecognized tax benefits at December 31, 2010.
The Company is subject to taxation in the United States and various states. The ma-
terial jurisdictions that are subject to examination by tax authorities primarily include
Minnesota and the United States, for tax years 2007, 2008, 2009 and 2010.
A reconciliation of the beginning and ending amounts of unrecognized tax benefit for
2010 and 2009 is as follows:
Balance at January 1, 2009 .............................................................
$
48,000
Expiration of the statute of limitations for the
assessment of taxes .........................................................................
Balance at December 31, 2009 ........................................................
Expiration of the statute of limitations for the
assessment of taxes .........................................................................
(21,000)
27,000
(27,000)
Balance at December 31, 2010 ........................................................
$
0
3. intangible assets
Intangible assets consist of patents, patent applications, licenses and covenants not to compete arising from business combinations. Capitalized patent application costs are
included with patents. Intangible assets are amortized on a straight-line basis over their estimated useful lives or terms of their agreement, whichever is shorter. In 2010 the
Company wrote off $31,000 of costs related to patent applications compared to $13,000 written off in 2009. No other impairment adjustments to intangible assets were made
during the year ended December 31, 2010 or 2009.
Intangible assets at December 31, 2010 and 2009 consist of the following:
december 31, 2010
december 31, 2009
Gross Carrying Amount
Accumulated Amortization
Gross Carrying Amount
Accumulated Amortization
amortized intangible assets:
Patents...........................................................................
$
291,151
$
(123,489)
$
268,116
$
(115,872)
Licenses .........................................................................
Non-compete agreements ...............................................
100,000
303,000
(67,500)
(185,994)
100,000
303,000
(59,376)
(150,328)
$
694,151
$
(376,983)
$
671,116
$
(325,576)
aggregate amortization expense:
For the years ended December 31
2010
$51,407
2009
Estimated amortization expense for the years ending december 31:
$55,251
2011 ........................................................................... $46,000
2012 ........................................................................... 46,000
2013 ........................................................................... 41,000
2014 ........................................................................... 12,000
2015 ...........................................................................
9,000
In connection with the license agreements, the Company has agreed to pay royalties ranging from 3% to 5% on the sales of products subject to the agreements. The Company
incurred $87,000 of expense under these agreements during 2010, and $74,000 during 2009 which have been included in selling, general and administrative expenses in the
Statements of Operations.
12
iKOniCS Corporation 2010 Annual Report
4. Retirement plan
The Company has established a salary deferral plan under Section 401(k) of the Internal Revenue Code. Such deferrals accumulate on a tax-deferred basis until the employee
withdraws the funds. The Company contributes up to 5% of each eligible employee’s compensation. Total retirement expense for the years ended December 31, 2010 and
2009 was approximately $188,000 and $175,000, respectively.
5. Segment information
The Company’s reportable segments are strategic business units that offer different products and have a varied customer base. There are three reportable segments: Domes-
tic, Export, and IKONICS Imaging.
Domestic sells screen printing film, emulsions, and inkjet receptive film which is sold to distributors located in the United States. IKONICS Imaging sells photo resistant film, art
supplies, glass, metal medium and related abrasive etching equipment to end user customers located in the United States. It is also in the market for etched industrial ceram-
ics, glass and silicon wafers, sound deadening products for aerospace; and is developing and selling proprietary inkjet technology. Export sells primarily the same products as
Domestic and IKONICS Imaging to foreign customers. The accounting policies applied to determine the segment information are the same as those described in the summary of
significant accounting policies.
Management evaluates the performance of each segment based on the components of divisional income, and with the exception for accounts receivable, does not allocate as-
sets and liabilities to segments. Financial information with respect to the reportable segments follows:
For the year ended december 31, 2010:
domestic
Export*
iKOniCS imaging
Other
Total
Net sales ........................................................................
$ 6,653,723
$ 5,420,601
$ 4,443,014
$
Cost of goods sold ..........................................................
Gross profit ....................................................................
Selling, general and Administrative ..................................
Research and Development .............................................
3,497,971
3,155,752
973,623
-
3,792,335
1,628,266
571,826
-
2,422,748
2,020,266
1,128,508
-
Income (loss) from Operations .........................................
$ 2,182,129
$ 1,056,440
$ 891,758
-
-
-
1,900,495
695,593
(2,596,088)
$ 16,517,338
9,713,054
6,804,284
4,574,452
695,593
1,534,239
For the year ended december 31, 2009:
domestic
Export*
iKOniCS imaging
Other
Total
Net sales ........................................................................
$ 6,788,355
$ 4,628,855
$ 3,704,407
$
Cost of goods sold ..........................................................
Gross profit ....................................................................
Selling, general and Administrative ..................................
Research and Development .............................................
3,589,054
3,199,301
944,273
-
3,400,896
1,227,959
552,616
-
2,064,821
1,639,586
1,112,485
-
-
-
-
1,934,074
653,747
$ 15,121,617
9,054,771
6,066,846
4,543,448
653,747
Income (loss) from Operations .........................................
$ 2,255,028
$
675,343
$
527,101
$
(2,587,821)
$
869,651
Trade receivables as of december 31, 2010 and 2009
2010
2009
Domestic ........................................................................
$
874,535
$
976,967
Export ............................................................................
IKONICS Imaging ............................................................
Other .............................................................................
725,007
325,334
(41,448)
740,547
331,117
(32,833)
Total ...............................................................................
$ 1,883,428
$ 2,015,798
* In 2010 and 2009, the Company marketed its products in various countries throughout the world. The Company is exposed to the risk of changes in social, political, and
economic conditions inherent in foreign operations, and the Company’s results of operations are affected by fluctuations in foreign currency exchange rates. No single foreign
country accounted for more than 10% of the Company’s net sales for 2010 and 2009.
Sales to foreign customers were 32.8% and 30.6% of the Company’s net sales for 2010 and 2009, respectively.
13
6. Stock Options
Black-Scholes option pricing model with the following assumptions:
The Company has a stock incentive plan for the issuance of up to 442,750 shares of
common stock. The plan provides for granting eligible participants stock options or
other stock awards, as described by the plan, at option prices ranging from 85% to
110% of fair market value at date of grant. Options granted expire up to seven years
after the date of grant. Such options generally become exercisable over a three
year period. A total of 125,573 shares of common stock are reserved for additional
grants of options under the plan at December 31, 2010.
Under the plan, the Company charged compensation cost of $29,417 and $23,650
against income in 2010 and 2009, respectively.
As of December 31, 2010, there was approximately $36,000 of unrecognized com-
pensation cost related to unvested share-based compensation awards granted which
is expected to be recognized over the next three years.
Proceeds from the exercise of stock options were $37,740 for 2010. There were no
options exercised in 2009.
The fair value of options granted during 2010 and 2009 were estimated using the
Dividend yield ..........................................................
Expected volatility ....................................................
2010
0%
45.2%
2009
0%
47.2%
Expected life of option .............................................
Five Years
Five Years
Risk-free interest rate ..............................................
Fair value of each option on grant date ....................
2.5%
$3.08
2.0%
$2.10
There were 4,000 options and 21,750 options granted during 2010 and 2009,
respectively.
FASB ASC 718, Compensation – Stock Compensation specifies that initial accruals
be based on the estimated number of instruments for which the requisite service
is expected to be rendered. Therefore, the Company is required to incorporate a
preexisting forfeiture rate based on the historical forfeiture expense and prospective
actuarial analysis, estimated at 2%.
A summary of the status of the Company’s stock option plan as of December 31, 2010 and changes during the year then ended is presented below:
Options
Outstanding at January 1, 2010
Granted
Exercised
Expired and forfeited
Outstanding at December 31, 2010
Vested or expected to vest at December 31, 2010
Exercisable at December 31, 2010
Shares
Weighted average Exercise price
Weighted average Remaining
Contractual Term (years)
aggregate intrinsic Value
45,500
4,000
(8,500)
(500)
40,500
40,500
19,583
$
$
$
$
5.91
7.39
4.44
5.00
6.38
6.38
6.95
2.65
2.65
1.88
$
$
$
38,386
38,386
11,593
The weighted-average grant date fair value of options granted was $3.08 and $2.10 for the years ended December 31, 2010 and 2009, respectively. The total intrinsic value of
options exercised was $24,945 for the year ended December 31, 2010. There were no options exercised in 2009.
The following table summarizes information about stock options outstanding at December 31, 2010:
Options Outstanding
Options Exercisable
Range of Exercise price
number Outstanding at decem-
ber 31, 2010
Weighted-average Remaining
Contractual life (years)
Weighted-average Exercise price
number Exercisable at december
31, 2010
Weighted- average Exercise price
$5.00 -$5.99
$6.00 -$6.99
$7.00 - $8.99
19,000
5,250
16,250
40,500
3.31
2.58
1.90
2.65
$
$
$
$
5.00
6.71
7.89
6.38
5,500
3,500
10,583
19,583
$
$
$
$
5.00
6.71
8.05
6.95
14
iKOniCS Corporation 2010 Annual Report
7. Concentration Of Credit Risk
The Company maintains its cash balances primarily at one financial institution in a partially insured checking account that does not provide for interest. Instead, the account
earns credits which offset banking fees.
Accounts receivable are financial instruments that also expose the Company to concentration of credit risk. The large number of customers comprising the Company’s customer
base and their dispersion across different geographic areas limits such exposure. In addition, the Company routinely assesses the financial strength of its customers and main-
tains an allowance for doubtful accounts that management believes will adequately provide for credit losses.
8. line Of Credit
The Company has a $1,250,000 bank line of credit that provides for working capital financing. This line of credit is subject to annual renewal on each October 31, is collateral-
ized by trade receivables and inventories, and bears interest at 2.5 percentage points over 30-day LIBOR. There were no outstanding borrowings under this line of credit at
December 31, 2010 and 2009. There are no financial covenants related to the line of credit.
Common Stock
Additional Financial Information
Stockholders of record automatically receive quarterly earnings information, and street
name holders may do so upon written request. For a copy of the Form 10-K, as filed
with the Securities and Exchange Commission, and other financial information avail-
able at no charge to stockholders, please contact:
JON GERLACH
Chief Financial Officer
IKONICS Corporation
4832 Grand Avenue, Duluth, MN 55807
Phone: (218) 628-2217
email: jgerlach@ikonics.com
Annual Meeting
The Company’s annual meeting will be held:
April 28, 2011 1:00 p.m.
Kitchi Gammi Club
831 E. Superior Street
Duluth, Minnesota 55802
IKONICS Corporation common stock is traded on the Nasdaq Capital Market under
the symbol IKNX. For investment and stock information contact:
JON GERLACH
Chief Financial Officer
IKONICS Corporation
4832 Grand Avenue, Duluth, MN 55807
Phone: (218) 628-2217
email: jgerlach@ikonics.com
Transfer Agent
WELLS FARGO SHAREOWNER SERVICES
PO Box 64854
St. Paul, MN 55164-0854
Shareholders with questions on stock holdings, transfer requirements and address
changes contact Wells Fargo Bank at: (651) 306-2955
Auditor
MCGLADREY & PULLEN LLP
700 Missabe Building
Duluth, Mn 55802
(218) 727-5025
Counsel
HANFT FRIDE
1000 U.S. Bank Place
130 W. Superior Street
Duluth, Mn 55802
(218) 722-4766
15
Corporate Officers
WILLIAM C. ULLAND
Chairman, president & CEO
CLAUDE PIGUET
Executive Vice president
JON GERLACH
Vice president, Finance, CFO
PARNELL THILL
Vice president, marketing
ROBERT D. BANKS
Vice president, international
Board of Directors
DAVID O. HARRIS
RONDI C. ERICKSON
LOCKWOOD CARLSON
CHARLES H. ANDRESEN
H. LEIGH SEVERANCE
GERALD W. SIMONSON
WILLIAM C. ULLAND
President
David O. Harris, Inc.
Minneapolis, MN
director Since 1965
Co-Owner
Nokomis Restaurant
Duluth, MN
director Since 2000
President
Carlson Consulting Group
Minneapolis, MN
director Since 2009
Attorney
Andresen & Butterworth P.A.
Duluth, MN
director Since 1979
President
Severance Capital Management
Denver, CO
director Since 2000
President
Omnetics Connector Corporation
Minneapolis, MN
director Since 1978
Chairman, President & CEO
IKONICS Corporation
Duluth, MN
director Since 1972
16
iKOniCS Corporation 2010 Annual Report
ContentS
letter to Shareholders ............................................................................1
management’s discussion and Analysis of
Financial Condition and Results of operations ..........................................2
Critical Accounting estimates ..................................................................2
Results of operations .............................................................................3
market for Common equity,
Related Stockholder matters and
issuer purchases of equity Securities .......................................................5
management’s Report ............................................................................5
management’s Annual Report on
internal Control over Financial Reporting .................................................5
Report of independent
Registered public Accounting Firm ..........................................................6
Balance Sheets ......................................................................................7
WilliAm C. ullAnd
Chairman, president & Ceo
CompAnY oVeRVieW
ChRomAline SCReen pRint pRoduCtS
globally respected brand, world-wide distribution and technical excellence through-
out the product portfolio, Chromaline continues to serve a critical, strategic role in
the stability and growth of ikoniCS.
Statements of operations .......................................................................8
ikoniCS imAging
Statements of Stockholders’ equity and Comprehensive income ................8
Statements of Cash Flows.......................................................................9
Serving the global awards and recognition market, ikoniCS imaging supplies a
consistent source of revenue and has proven a launch pad for many of ikoniCS’
newer ventures.
notes to Financial Statements .................................................................10
ikoniCS induStRiAl inkjet SolutionS
Board of directors/Corporate officers ......................................................16
ikoniCS Five-Year history .......................................................................Back Cover
Representing one of ikoniCS’ more recent enterprises, digital texturing is poised to
transform the way industrial textures are produced on a wide variety of consumer
and industrial products.
Recent progress on the development of a “direct to metal” application is promising
and represents a potentially critical competitive advantage.
CoRpoRAte pRoFile
ikoniCS miCRo-mAChining
2010 net Sales ................................................................................$16,517,338
earnings per common share (diluted) ............................................................ $0.56
Company founded ....................................................................................... 1952
employees ...................................................................................................... 72
nASdAq Symbol ......................................................................................... iknX
A broad-ranging line of products and services, micro-machining is an excellent
example of leveraging ikoniCS core technological and production competencies
to new markets, such as aerospace, advanced material machining and custom
coating solutions.
ikoniCS inteRnAtionAl
in 2010, ikoniCS recorded sales in 94 countries, representing virtually every offer-
ing within the ikoniCS product roster.
cover_folder 2010 final.indd 2
4/1/2011 8:38:41 AM
$16,000,000
$14,000,000
$12,000,000
$10,000,000
$8,000,000
$6,000,000
$4,000,000
$2,000,000
$0
Net Sales 2006 - 2010
Net Income (Loss) 2006 - 2010
$1,200,000
$1,000,000
$800,000
$600,000
$400,000
$200,000
$0
- $200,000
- $400,000
2006
2007
2008
2009
2010
2006
2007
2008
2009
2010
IKONICS Five-Year History
Net Sales
Pretax Income (Loss)
Net Income (Loss)
2006
2007
2008
2009
2010
$14,888,912
$15,824,725
$15,854,484
$15,121,617
$16,517,338
$1,589,765
$1,635,775
$1,085,134
$(11,360)
$1,553,920
$1,123,765
$1,169,775
$814,134
$(307,360)
$1,113,920
Net Cash Provided by Operations
$1,075,722
$1,697,695
$1,125,668
$1,374,114
$1,601,369
Return on Sales
Return on Assets
Return on Avg. Stockholders' Equity
Debt to Equity
Diluted EPS
Stock price: High
Low
Close
7.5%
10.5%
12.3%
8.9%
$0.55
7.4%
9.8%
11.2%
8.5%
$0.57
$10.47
$10.45
$6.26
$7.53
$7.22
$9.28
5.1%
6.5%
7.2%
9.2%
$0.40
$10.50
$5.25
$5.74
(2.0%)
(2.6%)
(2.7%)
8.8%
$(0.16)
$8.29
$4.00
$6.30
6.7%
8.5%
9.6%
7.8%
$0.56
$8.00
$6.30
$7.25
Weighted Average Common Shares Outstanding - Diluted
2,027,916
2,063,380
2,053,733
1,973,739
1,973,447
Total Assets
Total Liabilities
Total Stockholders' Equity
Capital Spending
$10,743,461
$11,982,417
$12,486,429
$11,997,272
$13,141,931
$879,362
$936,703
$1,052,789
$971,186
$948,984
$9,864,099
$11,045,714
$11,433,640
$11,026,086
$12,192,947
$273,548
$609,772
$4,472,681
$90,313
$189,150
20
1 0
AnnuAl RepoRt
ChRomAline
miCRo-mAChining SolutionS
ikoniCS imAging
induStRiAl inkjet SolutionS
inteRnAtionAl
4832 Grand Avenue Duluth, MN 55807 ph: (218) 628-2217 toll-free: (800) 328-4261 e: info@ikonics.com web: www.ikonics.com
nASdAq liSted: iknx
www.ikonics.com
cover_folder 2010 final.indd 1
4/1/2011 8:38:40 AM